Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | KCNN4 | O15554 | 5/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxytriphenylmethane SCHEMBL27882817 | 0.97 | MAPK1 (0.46) | MAPK1CYP19A1CES1KCNN4KIF11 | |
| SCHEMBL8785784 | 0.88 | CYP19A1 (0.44) | MAPK1CYP19A1CES1KCNN4KIF11 | |
| SCHEMBL15960119 | 0.86 | CYP19A1 (0.43) | MAPK1CYP19A1CES1KCNN4KIF11 | |
| SCHEMBL8784660 | 0.86 | CA4 (0.54) | CYP19A1CES1KIF11CA4 | |
| SCHEMBL774134 | 0.86 | CA4 (0.54) | CYP19A1CES1KIF11CA4 | |
| Hydrochloric Acid SCHEMBL30389842 | 0.84 | CA4 (0.52) | CYP19A1CES1KIF11ALDH1A1CA4 | |
| Bromide SCHEMBL31164184 | 0.84 | CA4 (0.52) | CYP19A1CES1KIF11CA4 | |
| SCHEMBL11091542 | 0.81 | CYP19A1 (0.37) | MAPK1CYP19A1CES1KCNN4KIF11 | |
| SCHEMBL5200151 | 0.81 | ALDH1A1 (0.48) | MAPK1CYP19A1CES1KCNN4KIF11 | |
| SCHEMBL8785612 | 0.79 | ACHE (0.45) | CYP19A1KIF11CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13253 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118345073-A | GalNAc derivative | 詹森生物制药有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-12030907-B2 | Modified nucleoside phosphoramidites | Janssen Biopharma, Inc. (US) | 2024-07-09 | — | — | US | claimed |
| US-20240218365-A1 | FORMULATION OF AN ANTISENSE OLIGOMER CONJUGATE | THE PROGERIA RESEARCH FOUNDATION, INC. | 2024-07-04 | — | — | US | claimed |
| EP-4392558-A1 | ANTISENSE OLIGONUCLEOTIDES HAVING ONE OR MORE ABASIC UNITS | Sarepta Therapeutics, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| EP-4387676-A2 | DELIVERY OF ANITSENSE OLIGOMERS BY MIRROR IMAGE PEPTIDES | Sarepta Therapeutics, Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| CN-115038790-B | Synthesis of 3' -RNA oligonucleotides | 阿尔尼拉姆医药品有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118184532-A | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-06-14 | — | — | CN | claimed |
| EP-4380624-A1 | MULTIVALENT LIGAND CLUSTERS WITH DIAMINE SCAFFOLD FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Shanghai Argo Biopharmaceutical Co., Ltd. (CN) | 2024-06-12 | — | — | EP | claimed |
| CN-112384520-B | Method for producing oligonucleotide compound | 日本新药株式会社 | 2024-06-11 | — | — | CN | claimed |
| CN-118146284-A | GalNAc compound, oligonucleotide conjugate and preparation method thereof | 北京悦康科创医药科技股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| EP-0177382-A1 | Mixed probe and its application, its precursor, its preparation and derivatives containing a modified base for this preparation | INSTITUT PASTEUR (FR) | 1986-04-09 | — | — | EP | claimed |
| EP-0135587-A4 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1986-04-02 | — | — | EP | claimed |
| EP-0135587-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1985-04-03 | — | — | EP | claimed |
| EP-0121635-A1 | 3',5',-Diarabinosides, their preparation and their therapeutical application | SYNTHELABO (FR) | 1984-10-17 | — | — | EP | claimed |
| EP-0121112-A1 | 2'-Deoxy-3-phosphonylmethyl nucleosides and method for their preparation | Gesellschaft für Biotechnologische Forschung mbH (GBF) (DE) | 1984-10-10 | — | — | EP | claimed |
| WO-1984003285-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS | MOLECULAR BIOSYSTEMS INC (US) | 1984-08-30 | — | — | WO | claimed |
| US-4458066-A | BOUND TO INORGANIC SUPPORT | UNIVERSITY PATENTS, INC. (US) | 1984-07-03 | — | — | US | claimed |
| EP-0058563-A1 | Lyophilized phosphorylated nucleosides | ens BIO LOGICALS INC. (CA) | 1982-08-25 | — | — | EP | claimed |
| EP-0049072-A1 | Guanine compounds and their use for the preparation of anti-viral agents | SYNTEX (U.S.A.) INC. (US) | 1982-04-07 | — | — | EP | claimed |
| EP-0035719-A2 | Process for producing modified inorganic polymers, their use in producing polynucleotides, and a reagent useful in these processes | UNIVERSITY PATENTS, INC. (US) | 1981-09-16 | — | — | EP | claimed |